imatinib mesylate has been researched along with Cachexia in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Araki, K; Harimoto, N; Hoshino, T; Ishii, N; Kakizaki, S; Kudo, T; Masuda, T; Naganuma, A; Ogawa, T; Ogawa, Y; Shirabe, K; Suzuki, Y; Tateno, K; Tateyama, Y; Uehara, S; Yasuoka, H | 1 |
1 other study(ies) available for imatinib mesylate and Cachexia
| Article | Year |
|---|---|
Imatinib and nutritional support can make successful treatment for a case of huge liver metastasis of duodenal gastrointestinal stromal tumor that initially showed jaundice and cachexia.
Topics: Adult; Antineoplastic Agents; Cachexia; Female; Gastrointestinal Stromal Tumors; Humans; Imatinib Mesylate; Jaundice; Liver Neoplasms; Neoplasm Recurrence, Local; Nutritional Support | 2021 |